JP2024511945A - 淋菌感染症の治療のための方法および材料 - Google Patents

淋菌感染症の治療のための方法および材料 Download PDF

Info

Publication number
JP2024511945A
JP2024511945A JP2023555485A JP2023555485A JP2024511945A JP 2024511945 A JP2024511945 A JP 2024511945A JP 2023555485 A JP2023555485 A JP 2023555485A JP 2023555485 A JP2023555485 A JP 2023555485A JP 2024511945 A JP2024511945 A JP 2024511945A
Authority
JP
Japan
Prior art keywords
alkyl
aryl
group
formula
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023555485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511945A5 (cg-RX-API-DMAC7.html
Inventor
ブイ. ラマチャンドラン,パディンジャーレマドホム
セレーム,モハメド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of JP2024511945A publication Critical patent/JP2024511945A/ja
Publication of JP2024511945A5 publication Critical patent/JP2024511945A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2023555485A 2021-03-26 2022-03-23 淋菌感染症の治療のための方法および材料 Pending JP2024511945A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166309P 2021-03-26 2021-03-26
US63/166,309 2021-03-26
PCT/US2022/021467 WO2022204231A2 (en) 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection

Publications (2)

Publication Number Publication Date
JP2024511945A true JP2024511945A (ja) 2024-03-18
JP2024511945A5 JP2024511945A5 (cg-RX-API-DMAC7.html) 2025-03-31

Family

ID=83398108

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555485A Pending JP2024511945A (ja) 2021-03-26 2022-03-23 淋菌感染症の治療のための方法および材料

Country Status (8)

Country Link
US (1) US20250339401A1 (cg-RX-API-DMAC7.html)
EP (1) EP4313040A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024511945A (cg-RX-API-DMAC7.html)
KR (1) KR20230161962A (cg-RX-API-DMAC7.html)
CN (1) CN117396201A (cg-RX-API-DMAC7.html)
AU (1) AU2022244356A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204231A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150719A1 (en) * 2022-02-03 2023-08-10 Purdue Research Foundation Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500289A (ja) * 2001-06-13 2005-01-06 マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド ラクトン処方物および使用方法
BRPI0620157A2 (pt) * 2005-12-15 2011-12-20 Activbiotics Pharma Llc usos de rifamicinas
US20210317099A1 (en) * 2020-04-09 2021-10-14 Purdue Research Foundation Safer, potent, and fast acting antimicrobial agents

Also Published As

Publication number Publication date
WO2022204231A3 (en) 2022-12-29
KR20230161962A (ko) 2023-11-28
CA3211535A1 (en) 2022-09-29
CN117396201A (zh) 2024-01-12
WO2022204231A2 (en) 2022-09-29
US20250339401A1 (en) 2025-11-06
EP4313040A2 (en) 2024-02-07
AU2022244356A1 (en) 2023-09-28
EP4313040A4 (en) 2025-02-12

Similar Documents

Publication Publication Date Title
JP7099824B2 (ja) 抗菌化合物
CN104470921B (zh) 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用
AU2020409843B2 (en) Novel compounds and their use
EP3057422B1 (en) Quinolinyl modulators of ror(gamma)t
WO2008081914A1 (ja) Plk1阻害剤としての新規アミノピリミジン誘導体
US20200165239A1 (en) Protein kinase inhibitors, preparation method and medical use thereof
US20240132515A1 (en) Toxin molecule suitable for antibody-drug conjugate
KR20240056750A (ko) Ahr 효능제
CN104211708B (zh) 苯并噁嗪酮衍生物及其作为抗菌剂的应用
RU2548031C2 (ru) Способ получения (+)-1,4-дигидро-7-[(3s,4s)-3-метокси-4-(метиламино)-1-пирролидинил]-4-оксо-1-(2-тиазолил)-1,8-нафтиридин-3-карбоновой кислоты
CN107459476B (zh) 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途
US20210317099A1 (en) Safer, potent, and fast acting antimicrobial agents
BRPI0911991B1 (pt) Derivados de 5-hidroximetil-oxazolidin-2-ona para o tratamento de doenças intestinais bacterianas
EA011359B1 (ru) Замещенные хинолины и их применение в качестве микобактериальных ингибиторов
CN114957296B (zh) 一类新型阿尔茨海默病检测探针及其生物应用
JPH0363274A (ja) 6,11―ジヒドロ―5H―ピリド[2,3―b][1,5]ベンゾジアゼピン―5―オン及び―チオン並びに該化合物のAIDSの予防又は治療における使用法
AU2022244356A1 (en) Methods and materials for treatment of neisseria gonorrhoeae infection
KR102650441B1 (ko) 내부 사이클릭 설피아미딘 아미드-아릴 아미드 화합물 및 이의 b형 간염 치료를 위한 용도
US12378211B2 (en) Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria
CA3161108C (en) Pyrido-azepine compounds and their uses as antibiotics
US20250195490A1 (en) Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)
CN117700351B (zh) 邻苯二甲酰亚胺类衍生物、包含其的药物组合物及其医药用途
CN109251158A (zh) 硫脒酰胺类化合物及其用于乙型肝炎治疗的用途
US20190256452A1 (en) Polyamine compounds targeting the efflux pumps of multi-drug resistant bacterial pathogens and methods of using the same
WO2020115547A2 (en) Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250321

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250321

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260407

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260703

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260707